India: Efficacy vs. Glimepiride

Why Glyxambi_Patient CRM_Banner_2x

Other benefits vs. Glimepiride

Long-term powerful efficacy of Empagliflozin vs. Glimepiride¹

Graph showing long-term efficacy of LINA vs. Glimepiride

FDC: Fixed-dose combination. HbAlc: Glycated haemoglobin. SE: Standard error. EMPA: Empagliflozin. LINA: Linagliptin. Cl: Confidence interval.

References:

Salsali A, et al. Diabetes Obes Metab. 2018; 20(12):2768-2777.
Gallwitz 8, et al. Lancet. 2012;380:475-83.

Long-term powerful efficacy of Linagliptin vs. Glimepiride¹

Feedback